Stay updated with breaking news from End Results Program. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Wasted indocyanine green (ICG) may be costing hospitals and patients millions of dollars each year, but reducing the ICG vial size could change that.
Talicia's efficacy and safety profile evaluated in patients with H. pylori infection and diabetes mellitus, a large and challenging patient population...
The risk of dying from liver cancer varies by race and ethnicity, particularly across subgroups of patients defined as “Asian/Pacific Islander.”
/PRNewswire/ -- Servier, a leader in oncology committed to bringing the promise of tomorrow to the patients we serve, today announced that the U.S. Food and...
TIBSOVO is the first therapy targeting cancer metabolism approved in combination with azacitidine for patients with newly diagnosed IDH1-mutated acute myeloid leukemia FDA approval based